Ocampo-Rojas, C., Cubas-Carrasco, P., Vidal-Vidal, Y., Delgado-Chaman, L., Zulueta-Cieza, L., Zambrano-Delgado, S., . . . Plasencia-Alvarez, J. O. (2024). Effects of SGLT2 inhibitors on hemoglobin levels in patients with chronic kidney disease: A bibliographic review.
Citación estilo ChicagoOcampo-Rojas, Criss, Paola Cubas-Carrasco, Yosy Vidal-Vidal, Leonardo Delgado-Chaman, Luz Zulueta-Cieza, Stefani Zambrano-Delgado, Jorge Vásquez-Evangelista, Juan Valladolid-Alzamora, y Jorge Omar Plasencia-Alvarez. Effects of SGLT2 Inhibitors On Hemoglobin Levels in Patients With Chronic Kidney Disease: A Bibliographic Review. 2024.
Cita MLAOcampo-Rojas, Criss, et al. Effects of SGLT2 Inhibitors On Hemoglobin Levels in Patients With Chronic Kidney Disease: A Bibliographic Review. 2024.